I guess you are being sarcastic. But with very good trial results and a partnership or takeover then it could be just a few months away. But I'll go for by the end of the year.
Biotechs are in boom atm. Big pharma has lots of money, following tax reform.
Yet ftt has gone from over 8c in November 2016 to now less than 5c now. But we have near time results, snippets of great looking data and enough funding, so the situation looks far far better now than it was when the sp was over 8c.
Timing the market is the key imho, and now is buy time.
ok, enough ranting, I'll keep quiet for a bit!
Best wishes.
FTT Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held